San Diego, CA -- (SBWire) -- 10/17/2022 --A deadline is coming up on October 17, 2022 in the lawsuit filed for certain investors of Ampio Pharmaceuticals, Inc. (NYSE: AMPE).
Investors who purchased shares of Ampio Pharmaceuticals, Inc. (NYSE: AMPE) have certain options and there are strict and short deadlines running. Deadline: October 17, 2022. Ampio Pharmaceuticals, Inc. (NYS: AMPE) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)779-1554.
The plaintiff alleges on behalf of purchasers of Ampio Pharmaceuticals, Inc. (NYSE: AMPE) common shares between December 29, 2020 and August 3, 2022, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between December 29, 2020 and August 3, 2022, the defendants, inflated the Company's true ability to successfully file a Biologics License Application for Ampion, inflated the results of the AP-013 study and the timing of unblinding the data from the AP-013 study, and that as a result, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.
Those who purchased shares of Ampio Pharmaceuticals, Inc. (NYSE: AMPE) have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com
About The Shareholders Foundation
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
NYSE:AMPE Investor Notice: Deadline on October 17, 2022 in Lawsuit Against Ampio Pharmaceuticals, Inc.
A Deadline is coming up on October 17, 2022 in the lawsuit for certain investors in Ampio Pharmaceuticals, Inc. (NYSE:AMPE).